K-numberK250246
Device nameuMR Jupiter
ApplicantShanghai United Imaging Healthcare Co., Ltd.
Product codeLNH
Device classClass II
Decision dateAug 5, 2025
DecisionSubstantially Equivalent
Regulation892.1000
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The uMR Jupiter is a 5T superconducting magnetic resonance diagnostic device that produces cross-sectional and spectroscopic images to display internal anatomical structure and function of the head, body, and extremities. It is intended for patients weighing more than 20 kg and assists in clinical diagnosis when interpreted by trained physicians.

Technological characteristics

The proposed device maintains identical core specifications to the predicate: 5.0 Tesla superconducting magnet with 60 cm bore, 120 mT/m maximum gradient amplitude, 200 T/m/s slew rate, 8-channel RF transmit system with 210.794 MHz resonant frequency, and 96 receive channels. Modifications include two new RF coils (SuperFlex Large-24 and Foot & Ankle Coil-24), five new pulse sequences, and seven new software functions (EasyScan, EasyCrop, t-ACS, QScan, tFAST, DeepRecon, WFI) compared to the predicate.

Test standards cited

IEC 60601 series (electrical safety and EMC), IEC 60601-2-33 (MR-specific safety), IEC 62464-1 (image quality parameters), NEMA MS standards (SNR, geometric distortion, uniformity, slice thickness, SAR, RF coil heating), ISO 10993 (biocompatibility), ISO 14971 (risk management), 21 CFR Part 820 (quality systems), and NEMA PS 3 DICOM standards.

Substantial equivalence argument

The proposed device employs identical fundamental MR technology and basic operating principles as the predicate device with the same indications for use. New RF coils are functionally equivalent to existing coils—SuperFlex Large-24 is a larger variant of SuperFlex Small-24 for the same anatomical regions, and Foot & Ankle Coil-24 has established precedent in reference devices. New pulse sequences and software functions (which incorporate machine learning algorithms like t-ACS and DeepRecon) were validated through non-clinical testing including image quality assessment by board-certified radiologists, demonstrating they produce diagnostically equivalent or superior images without raising new safety concerns. Extensive performance testing on diverse patient populations confirmed the device meets clinical diagnostic requirements, establishing substantial equivalence despite these incremental enhancements.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →